1
|
Abstract
MicroRNAs (miRNAs) are small noncoding elements that play essential roles in the posttranscriptional regulation of biochemical processes. miRNAs recognize and target multiple mRNAs; therefore, investigating miRNA dysregulation is an indispensable strategy to understand pathological conditions and to design innovative drugs. Targeting miRNAs in diseases improve outcomes of several therapeutic strategies thus, this present study highlights miRNA targeting methods through experimental assays and bioinformatics tools. The first part of this review focuses on experimental miRNA targeting approaches for elucidating key biochemical pathways. A growing body of evidence about the miRNA world reveals the fact that it is not possible to uncover these molecules' structural and functional characteristics related to the biological processes with a deterministic approach. Instead, a systemic point of view is needed to truly understand the facts behind the natural complexity of interactions and regulations that miRNA regulations present. This task heavily depends both on computational and experimental capabilities. Fortunately, several miRNA bioinformatics tools catering to nonexperts are available as complementary wet-lab approaches. For this purpose, this work provides recent research and information about computational tools for miRNA targeting research.
Collapse
Affiliation(s)
- Hossein Ghanbarian
- Biotechnology Department & Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Mehmet Taha Yıldız
- Division of Molecular Medicine, Hamidiye Institute of Health Sciences, University of Health Sciences-Turkey, Istanbul, Turkey
| | - Yusuf Tutar
- Division of Biochemistry, Department of Basic Pharmaceutical Sciences, Hamidiye Faculty of Pharmacy & Division of Molecular Medicine, Hamidiye Institute of Health Sciences, University of Health Sciences-Turkey, Istanbul, Turkey.
| |
Collapse
|
2
|
den Ridder M, Daran-Lapujade P, Pabst M. Shot-gun proteomics: why thousands of unidentified signals matter. FEMS Yeast Res 2019; 20:5682490. [DOI: 10.1093/femsyr/foz088] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2019] [Accepted: 12/19/2019] [Indexed: 12/14/2022] Open
Abstract
ABSTRACT
Mass spectrometry-based proteomics has become a constitutional part of the multi-omics toolbox in yeast research, advancing fundamental knowledge of molecular processes and guiding decisions in strain and product developmental pipelines. Nevertheless, post-translational protein modifications (PTMs) continue to challenge the field of proteomics. PTMs are not directly encoded in the genome; therefore, they require a sensitive analysis of the proteome itself. In yeast, the relevance of post-translational regulators has already been established, such as for phosphorylation, which can directly affect the reaction rates of metabolic enzymes. Whereas, the selective analysis of single modifications has become a broadly employed technique, the sensitive analysis of a comprehensive set of modifications still remains a challenge. At the same time, a large number of fragmentation spectra in a typical shot-gun proteomics experiment remain unidentified. It has been estimated that a good proportion of those unidentified spectra originates from unexpected modifications or natural peptide variants. In this review, recent advancements in microbial proteomics for unrestricted protein modification discovery are reviewed, and recent research integrating this additional layer of information to elucidate protein interaction and regulation in yeast is briefly discussed.
Collapse
Affiliation(s)
- Maxime den Ridder
- Delft University of Technology, Department of Biotechnology, van der Maasweg 9, 2629 HZ Delft, The Netherlands
| | - Pascale Daran-Lapujade
- Delft University of Technology, Department of Biotechnology, van der Maasweg 9, 2629 HZ Delft, The Netherlands
| | - Martin Pabst
- Delft University of Technology, Department of Biotechnology, van der Maasweg 9, 2629 HZ Delft, The Netherlands
| |
Collapse
|
3
|
Boisselier É, Demers É, Cantin L, Salesse C. How to gather useful and valuable information from protein binding measurements using Langmuir lipid monolayers. Adv Colloid Interface Sci 2017; 243:60-76. [PMID: 28372794 DOI: 10.1016/j.cis.2017.03.004] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2016] [Revised: 03/14/2017] [Accepted: 03/15/2017] [Indexed: 12/22/2022]
Abstract
This review presents data on the influence of various experimental parameters on the binding of proteins onto Langmuir lipid monolayers. The users of the Langmuir methodology are often unaware of the importance of choosing appropriate experimental conditions to validate the data acquired with this method. The protein Retinitis pigmentosa 2 (RP2) has been used throughout this review to illustrate the influence of these experimental parameters on the data gathered with Langmuir monolayers. The methods detailed in this review include the determination of protein binding parameters from the measurement of adsorption isotherms, infrared spectra of the protein in solution and in monolayers, ellipsometric isotherms and fluorescence micrographs.
Collapse
Affiliation(s)
- Élodie Boisselier
- CUO-Recherche, Hôpital du Saint-Sacrement, Centre de recherche du CHU de Québec and Département d'ophtalmologie, Faculté de médecine, and Regroupement stratégique PROTEO, Université Laval, Québec, Québec, Canada.
| | - Éric Demers
- CUO-Recherche, Hôpital du Saint-Sacrement, Centre de recherche du CHU de Québec and Département d'ophtalmologie, Faculté de médecine, and Regroupement stratégique PROTEO, Université Laval, Québec, Québec, Canada
| | - Line Cantin
- CUO-Recherche, Hôpital du Saint-Sacrement, Centre de recherche du CHU de Québec and Département d'ophtalmologie, Faculté de médecine, and Regroupement stratégique PROTEO, Université Laval, Québec, Québec, Canada
| | - Christian Salesse
- CUO-Recherche, Hôpital du Saint-Sacrement, Centre de recherche du CHU de Québec and Département d'ophtalmologie, Faculté de médecine, and Regroupement stratégique PROTEO, Université Laval, Québec, Québec, Canada.
| |
Collapse
|
4
|
Abstract
Scoring functions that assess spectrum similarity play a crucial role in many computational mass spectrometry algorithms. These functions are used to compare an experimentally acquired fragmentation (MS/MS) spectrum against two different types of target MS/MS spectra: either against a theoretical MS/MS spectrum derived from a peptide from a sequence database, or against another, previously acquired MS/MS spectrum. The former is typically encountered in database searching, while the latter is used in spectrum clustering and spectral library searching. The comparison between acquired versus theoretical MS/MS spectra is most commonly performed using cross-correlations or probability derived scoring functions, while the comparison of two acquired MS/MS spectra typically makes use of a normalized dot product, especially in spectrum library search algorithms. In addition to these scoring functions, Pearson's or Spearman's correlation coefficients, mean squared error, or median absolute deviation scores can also be used for the same purpose. Here, we describe and evaluate these scoring functions with regards to their ability to assess spectrum similarity for theoretical versus acquired, and acquired versus acquired spectra.
Collapse
Affiliation(s)
- Şule Yilmaz
- Medical Biotechnology Center, VIB, Albert Baertsoenkaai 3, Ghent, 9000, Belgium
- Department of Biochemistry, Ghent University, Ghent, 9000, Belgium
- Bioinformatics Institute Ghent, Ghent University, Ghent, 9000, Belgium
| | - Elien Vandermarliere
- Medical Biotechnology Center, VIB, Albert Baertsoenkaai 3, Ghent, 9000, Belgium
- Department of Biochemistry, Ghent University, Ghent, 9000, Belgium
- Bioinformatics Institute Ghent, Ghent University, Ghent, 9000, Belgium
| | - Lennart Martens
- Medical Biotechnology Center, VIB, Albert Baertsoenkaai 3, Ghent, 9000, Belgium.
- Department of Biochemistry, Ghent University, Ghent, 9000, Belgium.
- Bioinformatics Institute Ghent, Ghent University, Ghent, 9000, Belgium.
| |
Collapse
|
5
|
Computational and statistical methods for high-throughput analysis of post-translational modifications of proteins. J Proteomics 2015. [PMID: 26216596 DOI: 10.1016/j.jprot.2015.07.016] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The investigation of post-translational modifications (PTMs) represents one of the main research focuses for the study of protein function and cell signaling. Mass spectrometry instrumentation with increasing sensitivity improved protocols for PTM enrichment and recently established pipelines for high-throughput experiments allow large-scale identification and quantification of several PTM types. This review addresses the concurrently emerging challenges for the computational analysis of the resulting data and presents PTM-centered approaches for spectra identification, statistical analysis, multivariate analysis and data interpretation. We furthermore discuss the potential of future developments that will help to gain deep insight into the PTM-ome and its biological role in cells. This article is part of a Special Issue entitled: Computational Proteomics.
Collapse
|
6
|
Spencer JL, Bhatia VN, Whelan SA, Costello CE, McComb ME. STRAP PTM: Software Tool for Rapid Annotation and Differential Comparison of Protein Post-Translational Modifications. CURRENT PROTOCOLS IN BIOINFORMATICS 2013; 44:13.22.1-36. [PMID: 25422678 PMCID: PMC4240648 DOI: 10.1002/0471250953.bi1322s44] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
The identification of protein post-translational modifications (PTMs) is an increasingly important component of proteomics and biomarker discovery, but very few tools exist for performing fast and easy characterization of global PTM changes and differential comparison of PTMs across groups of data obtained from liquid chromatography-tandem mass spectrometry experiments. STRAP PTM (Software Tool for Rapid Annotation of Proteins: Post-Translational Modification edition) is a program that was developed to facilitate the characterization of PTMs using spectral counting and a novel scoring algorithm to accelerate the identification of differential PTMs from complex data sets. The software facilitates multi-sample comparison by collating, scoring, and ranking PTMs and by summarizing data visually. The freely available software (beta release) installs on a PC and processes data in protXML format obtained from files parsed through the Trans-Proteomic Pipeline. The easy-to-use interface allows examination of results at protein, peptide, and PTM levels, and the overall design offers tremendous flexibility that provides proteomics insight beyond simple assignment and counting.
Collapse
Affiliation(s)
- Jean L. Spencer
- Cardiovascular Proteomics Center, Boston University School of
Medicine, 670 Albany Street, Room 504, Boston, MA 02118-2526, Phone:
617-638-4537
| | - Vivek N. Bhatia
- Cardiovascular Proteomics Center, Boston University School of
Medicine, 670 Albany Street, Room 504, Boston, MA 02118-2526, Phone:
617-638-6760
| | - Stephen A. Whelan
- Cardiovascular Proteomics Center, Boston University School of
Medicine, 670 Albany Street, Room 504, Boston, MA 02118-2526, Phone:
617-638-6760
| | - Catherine E. Costello
- Cardiovascular Proteomics Center, Boston University School of
Medicine, 670 Albany Street, Room 507, Boston, MA 02118-2526, Phone:
617-638-6490
| | - Mark E. McComb
- Cardiovascular Proteomics Center, Boston University School of
Medicine, 670 Albany Street, Room 511, Boston, MA 02118-2526, Phone:
617-638-4280
| |
Collapse
|
7
|
Abstract
The rapid technological developments following the Human Genome Project have made possible the availability of personalized genomes. As the focus now shifts from characterizing genomes to making personalized disease associations, in combination with the availability of other omics technologies, the next big push will be not only to obtain a personalized genome, but to quantitatively follow other omics. This will include transcriptomes, proteomes, metabolomes, antibodyomes, and new emerging technologies, enabling the profiling of thousands of molecular components in individuals. Furthermore, omics profiling performed longitudinally can probe the temporal patterns associated with both molecular changes and associated physiological health and disease states. Such data necessitates the development of computational methodology to not only handle and descriptively assess such data, but also construct quantitative biological models. Here we describe the availability of personal genomes and developing omics technologies that can be brought together for personalized implementations and how these novel integrated approaches may effectively provide a precise personalized medicine that focuses on not only characterization and treatment but ultimately the prevention of disease.
Collapse
|
8
|
|